Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

Amarin (AMRN) +9% following a report that Teva (TEVA +0.7%) is leading the race to acquire the...

  • Thursday, November 15, 2012, 8:28 AM ET
    Amarin (AMRN) +9% following a report that Teva (TEVA +0.7%) is leading the race to acquire the Irish biotech, which has a market cap of $1.6B, with AstraZeneca (AZN +0.4%) also in the hunt. Teva recently said it wasn't intending to make any major acquisitions, while it's also due to unveil a long-term overhaul in December.
Track new comments on this story

This news story has 3 comments:

  •  
    I'll believe it when I see it reported in a reliable news organzation's stories. Too long with nothing for now! But I'm a holder.
    15 Nov 2012, 09:56 AM Reply Like
  •  
    teva alredy buy amarin.thay just wait until 11/12 to say that.
    15 Nov 2012, 01:04 PM Reply Like
  •  
    How did you happen to acquire that juicy tidbit of information?
    15 Nov 2012, 01:23 PM Reply Like
LATEST|
TODAY SO FAR|
YESTERDAY
Other date
DJIA (DIA) S&P 500 (SPY)

HEALTHCARE ETFs IN FOCUS

Latest Healthcare Articles
More Latest Articles »